These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38973608)

  • 21. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
    J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells.
    Seki S; Nakashima H; Nakashima M; Kinoshita M
    Clin Dev Immunol; 2011; 2011():868345. PubMed ID: 22190974
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C
    Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen Receptor Blockade Potentiates Immunotherapy for Liver Metastases by Altering the Liver Immunosuppressive Microenvironment.
    Benslimane Y; Amalfi K; Lapin S; Perrino S; Brodt P
    Cancer Res Commun; 2024 Aug; 4(8):1963-1977. PubMed ID: 39007345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.
    Iraolagoitia XL; Spallanzani RG; Torres NI; Araya RE; Ziblat A; Domaica CI; Sierra JM; Nuñez SY; Secchiari F; Gajewski TF; Zwirner NW; Fuertes MB
    J Immunol; 2016 Aug; 197(3):953-61. PubMed ID: 27342842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK cells mediate clearance of CD8
    Nicolai CJ; Wolf N; Chang IC; Kirn G; Marcus A; Ndubaku CO; McWhirter SM; Raulet DH
    Sci Immunol; 2020 Mar; 5(45):. PubMed ID: 32198222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
    Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
    Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8
    Yang Z; Wang X; Fu Y; Wu W; Hu Z; Lin Q; Peng W; Pan Y; Wang J; Chen J; Hu D; Zhou Z; Xu L; Zhang Y; Hou J; Chen M
    Mol Cancer; 2024 Sep; 23(1):186. PubMed ID: 39237909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.
    Knudson KM; Hicks KC; Ozawa Y; Schlom J; Gameiro SR
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation.
    Caudana P; Núñez NG; De La Rochere P; Pinto A; Denizeau J; Alonso R; Niborski LL; Lantz O; Sedlik C; Piaggio E
    Cancer Immunol Res; 2019 Mar; 7(3):443-457. PubMed ID: 30651291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
    J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
    Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.
    Diggs LP; Ruf B; Ma C; Heinrich B; Cui L; Zhang Q; McVey JC; Wabitsch S; Heinrich S; Rosato U; Lai W; Subramanyam V; Longerich T; Loosen SH; Luedde T; Neumann UP; Desar S; Kleiner D; Gores G; Wang XW; Greten TF
    J Hepatol; 2021 May; 74(5):1145-1154. PubMed ID: 33276030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors.
    Fan Z; Yu P; Wang Y; Wang Y; Fu ML; Liu W; Sun Y; Fu YX
    Blood; 2006 Feb; 107(4):1342-51. PubMed ID: 16223768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    Li H; Han Y; Guo Q; Zhang M; Cao X
    J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction.
    Abdel-Rahman SA; Zhang L; Gabr MT
    SLAS Discov; 2023 Jun; 28(4):188-192. PubMed ID: 37121273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.